264 related articles for article (PubMed ID: 24872589)
21. Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.
Murphy J; Hall WW; Ratner L; Sheehy N
Virology; 2016 Jul; 494():129-42. PubMed ID: 27110706
[TBL] [Abstract][Full Text] [Related]
22. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
Polakowski N; Gregory H; Mesnard JM; Lemasson I
Retrovirology; 2010 Jul; 7():61. PubMed ID: 20653953
[TBL] [Abstract][Full Text] [Related]
23. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.
Hagiya K; Yasunaga J; Satou Y; Ohshima K; Matsuoka M
Retrovirology; 2011 Mar; 8():19. PubMed ID: 21414204
[TBL] [Abstract][Full Text] [Related]
24. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.
Halin M; Douceron E; Clerc I; Journo C; Ko NL; Landry S; Murphy EL; Gessain A; Lemasson I; Mesnard JM; Barbeau B; Mahieux R
Blood; 2009 Sep; 114(12):2427-38. PubMed ID: 19602711
[TBL] [Abstract][Full Text] [Related]
25. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
Matsumoto J; Ohshima T; Isono O; Shimotohno K
Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.
Yin H; Kannian P; Dissinger N; Haines R; Niewiesk S; Green PL
J Virol; 2012 Aug; 86(16):8412-21. PubMed ID: 22623800
[TBL] [Abstract][Full Text] [Related]
27. HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.
Rushing AW; Rushing B; Hoang K; Sanders SV; Péloponèse JM; Polakowski N; Lemasson I
PLoS Pathog; 2019 Jun; 15(6):e1007922. PubMed ID: 31251786
[TBL] [Abstract][Full Text] [Related]
28. Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Shichijo T; Yasunaga JI; Sato K; Nosaka K; Toyoda K; Watanabe M; Zhang W; Koyanagi Y; Murphy EL; Bruhn RL; Koh KR; Akari H; Ikeda T; Harris RS; Green PL; Matsuoka M
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2309925121. PubMed ID: 38502701
[TBL] [Abstract][Full Text] [Related]
29. HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.
Zhao T; Satou Y; Sugata K; Miyazato P; Green PL; Imamura T; Matsuoka M
Blood; 2011 Aug; 118(7):1865-76. PubMed ID: 21705495
[TBL] [Abstract][Full Text] [Related]
30. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells.
Ma G; Yasunaga J; Fan J; Yanagawa S; Matsuoka M
Oncogene; 2013 Sep; 32(36):4222-30. PubMed ID: 23045287
[TBL] [Abstract][Full Text] [Related]
31. Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.
Raval GU; Bidoia C; Forlani G; Tosi G; Gessain A; Accolla RS
Retrovirology; 2015 Jul; 12():59. PubMed ID: 26140924
[TBL] [Abstract][Full Text] [Related]
32. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.
Cavanagh MH; Landry S; Audet B; Arpin-André C; Hivin P; Paré ME; Thête J; Wattel E; Marriott SJ; Mesnard JM; Barbeau B
Retrovirology; 2006 Mar; 3():15. PubMed ID: 16512901
[TBL] [Abstract][Full Text] [Related]
33. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization.
Tanaka-Nakanishi A; Yasunaga J; Takai K; Matsuoka M
Cancer Res; 2014 Jan; 74(1):188-200. PubMed ID: 24177179
[TBL] [Abstract][Full Text] [Related]
34. HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.
Terol M; Gazon H; Lemasson I; Duc-Dodon M; Barbeau B; Césaire R; Mesnard JM; Péloponèse JM
Leukemia; 2017 Oct; 31(10):2235-2243. PubMed ID: 28260789
[TBL] [Abstract][Full Text] [Related]
35. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs).
Barbeau B; Mesnard JM
Viruses; 2011 May; 3(5):456-68. PubMed ID: 21994742
[TBL] [Abstract][Full Text] [Related]
36. The Role of HBZ in HTLV-1-Induced Oncogenesis.
Zhao T
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
[TBL] [Abstract][Full Text] [Related]
37. Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.
Dubuisson L; Lormières F; Fochi S; Turpin J; Pasquier A; Douceron E; Oliva A; Bazarbachi A; Lallemand-Breitenbach V; De Thé H; Journo C; Mahieux R
Oncogene; 2018 May; 37(21):2806-2816. PubMed ID: 29507418
[TBL] [Abstract][Full Text] [Related]
38. The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB.
Ma Y; Zheng S; Wang Y; Zang W; Li M; Wang N; Li P; Jin J; Dong Z; Zhao G
Mol Biol Rep; 2013 Oct; 40(10):5967-75. PubMed ID: 24065533
[TBL] [Abstract][Full Text] [Related]
39. HTLV-1 basic leucine zipper factor downregulates cyclin D1 expression via interactions with NF-κB.
Ma Y; Zhang B; Wang D; Qian L; Song X; Wang X; Yang C; Zhao G
Int J Mol Med; 2017 Mar; 39(3):764-770. PubMed ID: 28204810
[TBL] [Abstract][Full Text] [Related]
40. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
